Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma

被引:247
作者
Gumz, Michelle L.
Zou, Hongzhi
Kreinest, Pamela A.
Childs, April C.
Belmonte, Leandra S.
LeGrand, Shauna N.
Wu, Kevin J.
Luxon, Bruce A.
Sinha, Mala
Parker, Alexander S.
Sun, L-Z.
Ahlquist, David A.
Wood, Christopher G.
Copland, John A.
机构
[1] Mayo Clin, Coll Med, Mayo Clin Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA
[2] Mayo Clin Jacksonville, Dept Pathol, Jacksonville, FL 32224 USA
[3] Mayo Clin Jacksonville, Dept Urol, Jacksonville, FL 32224 USA
[4] Mayo Clin, Dept Gastroenterol & Hepatol, Rochester, MN USA
[5] Univ Texas, Med Branch, Bioinformat Program, Galveston, TX 77550 USA
[6] Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX USA
[7] Univ Texas, MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
关键词
D O I
10.1158/1078-0432.CCR-07-0143
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Incidence and mortality rates for renal cell carcinoma (RCC) have been rising for decades. Unfortunately, the molecular events that support RCC carcinogenesis remain poorly understood. In an effort to gain a better understanding of signaling events in clear cell RCC (cRCC), we investigated the antitumor activity of secreted frizzled-related protein 1 (sFRP1), a negative regulator of Wnt signaling. Experimental Design: Genomic profiling of cRCC tumors and patient-matched normal tissues was done and confirmed using quantitative PCR and immunohistochemistry. Methylation-specific PCR was done on patient samples to evaluate the mechanism responsible for sFRP1 loss. sFRP1 expression was restored in cRCC cells and the effects on tumor phenotype were characterized. Results: Genomic profiling, quantitative PCR, and immunohistochemistry indicated that loss of sFRP1 occurred in cRCC and papillary RCC patient tissues. Twelve Wnt-regulated genes were up-regulated in cRCC tissues, including c-myc and cyclin D1, potentiators of cell proliferation and survival. Methylation of the sFRP1 gene was one mechanism identified for attenuation of sFRP1 mRNA. Stable reexpression of sFRP1 in cRCC cells resulted in decreased expression of Wnt target genes, decreased growth in cell culture, inhibition of anchorage-independent growth, and decreased tumor growth in athymic nude mice. Conclusions: To our knowledge, this is the first report to show that stable restoration of sFRP1 expression in cRCC cells attenuates the cRCC tumor phenotype. Our data support a role for sFRP1 as a tumor suppressor in cRCC and that perhaps loss of sFRP1 is an early, aberrant molecular event in renal cell carcinogenesis.
引用
收藏
页码:4740 / 4749
页数:10
相关论文
共 52 条
[1]  
Bilim V, 2000, CLIN CANCER RES, V6, P460
[2]   The Wnt antagonist sFRP1 in colorectal tumorigenesis [J].
Caldwell, GM ;
Jones, C ;
Gensberg, K ;
Jan, S ;
Hardy, RG ;
Byrd, P ;
Chughtai, S ;
Wallis, Y ;
Matthews, GM ;
Morton, DG .
CANCER RESEARCH, 2004, 64 (03) :883-888
[3]   Docosahexaenoic acid induces proteasome-dependent degradation of β-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2 [J].
Calviello, Gabriella ;
Resci, Federica ;
Serini, Simona ;
Piccioni, Elisabetta ;
Toesca, Amelia ;
Boninsegna, Alma ;
Monego, Giovanni ;
Ranelletti, Franco O. ;
Palozza, Paola .
CARCINOGENESIS, 2007, 28 (06) :1202-1209
[4]   Targeting bone metastasis in prostate cancer with endothelin receptor antagonists [J].
Carducci, Michael A. ;
Jimeno, Antonio .
CLINICAL CANCER RESEARCH, 2006, 12 (20) :6296S-6300S
[5]   Rising incidence of renal cell cancer in the United States [J].
Chow, WH ;
Devesa, SS ;
Warren, JL ;
Fraumeni, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17) :1628-1631
[6]   Wnt/β-catenin signaling in development and disease [J].
Clevers, Hans .
CELL, 2006, 127 (03) :469-480
[7]   Genomic profiling identifies alterations in TGFβ signaling through loss of TGFβ receptor expression in human renal cell carcinogenesis and progression [J].
Copland, JA ;
Luxon, BA ;
Ajani, L ;
Maity, T ;
Campagnaro, E ;
Guo, HP ;
LeGrand, SN ;
Tamboli, P ;
Wood, CG .
ONCOGENE, 2003, 22 (39) :8053-8062
[8]   The use of DNA microarrays to assess clinical samples: The transition from bedside to bench to bedside [J].
Copland, JA ;
Davies, PJ ;
Shipley, GL ;
Wood, CG ;
Luxon, BA ;
Urban, RJ .
RECENT PROGRESS IN HORMONE RESEARCH, VOL 58: HUMAN GENOME AND ENDOCRINOLOGY, 2003, 58 :25-53
[9]  
DAHL E, 2007, ONCOGENE 0312
[10]   Secreted frizzled related protein 1 is overexpressed in uterine leiomyomas, associated with a high estrogenic environment and unrelated to proliferative activity [J].
Fukuhara, K ;
Kariya, M ;
Kita, M ;
Shime, H ;
Kanamori, T ;
Kosaka, C ;
Orii, A ;
Fujita, J ;
Fujii, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1729-1736